Attentive Science
Attentive Science is dedicated to advancing non-clinical research to improve healthcare outcomes. They serve diverse industries including biotechnology, pharmaceuticals, animal health, and agrochemicals. The company offers a wide range of preclinical solutions such as pharmacokinetics, toxicology, safety pharmacology, histology, and in-vivo pharmacology services. With a focus on innovation, collaboration, and quality, Attentive Science aims to support clients in developing cures and remedies through precise and efficient research services.
Industries
Nr. of Employees
small (1-50)
Attentive Science
Stilwell, Kansas, United States
Products
High Throughput PK
Pharmacokinetic assessment of compounds and test substances to provide a quick read on whether a product is druggable through in-vivo dose formulation and assessment.
Formulation Screening
Formulation of test substances in several vehicles, administration into a test system, and collection of blood samples to determine presence and pharmacokinetic data endpoints.
Discovery
Early phase discovery toxicology studies designed to assess exposure and potential toxicity of test compounds after single or multiple administrations.
Long Term PK
Characterization of relatively longer half-life substances, small molecules, biologics, or extended-release formulations to fully understand in-vivo pharmacokinetic profiles.
Dose Range Finding
Preliminary in-vivo toxicity studies to determine appropriate doses for single and multiple dose studies through test substance tolerance assays.
Acute Chronic Subchronic
Evaluation of potential acute effects on target organs subsequent to test substance administration to guide sub-chronic and chronic study designs.
High Throughput PK
Pharmacokinetic assessment of compounds and test substances to provide a quick read on whether a product is druggable through in-vivo dose formulation and assessment.
Formulation Screening
Formulation of test substances in several vehicles, administration into a test system, and collection of blood samples to determine presence and pharmacokinetic data endpoints.
Discovery
Early phase discovery toxicology studies designed to assess exposure and potential toxicity of test compounds after single or multiple administrations.
Long Term PK
Characterization of relatively longer half-life substances, small molecules, biologics, or extended-release formulations to fully understand in-vivo pharmacokinetic profiles.
Dose Range Finding
Preliminary in-vivo toxicity studies to determine appropriate doses for single and multiple dose studies through test substance tolerance assays.
Acute Chronic Subchronic
Evaluation of potential acute effects on target organs subsequent to test substance administration to guide sub-chronic and chronic study designs.
Services
End-to-end toxicology study services from discovery toxicology through regulatory-enabling studies to evaluate dose-related adverse effects and support candidate selection and regulatory filings.
In-vivo PK/TK services including high-throughput and long-term studies to characterize exposure and guide dose selection for downstream studies.
Safety pharmacology assessments to detect potential undesirable pharmacodynamic effects on physiological systems, with dedicated CNS safety evaluations.
Tissue processing and histology slide production including fixation, embedding, microtomy, staining, immunohistochemistry and immunofluorescence.
In-vitro biomarker and assay services including ELISA, flow cytometry, PCR, Western blot, cytotoxicity assays, cell culture, transfection, and custom assay development.
Standardized genetic toxicology testing including Ames, micronucleus, and chromosome aberration assays following relevant OECD guidelines.
End-to-end toxicology study services from discovery toxicology through regulatory-enabling studies to evaluate dose-related adverse effects and support candidate selection and regulatory filings.
In-vivo PK/TK services including high-throughput and long-term studies to characterize exposure and guide dose selection for downstream studies.
Safety pharmacology assessments to detect potential undesirable pharmacodynamic effects on physiological systems, with dedicated CNS safety evaluations.
Tissue processing and histology slide production including fixation, embedding, microtomy, staining, immunohistochemistry and immunofluorescence.
In-vitro biomarker and assay services including ELISA, flow cytometry, PCR, Western blot, cytotoxicity assays, cell culture, transfection, and custom assay development.
Standardized genetic toxicology testing including Ames, micronucleus, and chromosome aberration assays following relevant OECD guidelines.
Expertise Areas
- Preclinical toxicology
- Safety pharmacology (including CNS)
- Pharmacokinetics and toxicokinetics
- Histology and tissue-based assays (IHC/IF)
Key Technologies
- In-vivo pharmacokinetic (PK/TK) studies
- High-throughput in-vivo PK
- SEND (Standard for Exchange of Nonclinical Data)
- Immunoassays (ELISA)
News & Updates
Attentive Science is proud to exhibit across three international pavilions at the BIO International Convention 2025.
Join Attentive at the NorCal SOT Spring Symposium 2025, a premier event for toxicology professionals.
Attentive Science is excited to attend the 64th Annual Society of Toxicology (SOT) Meeting & ToxExpo in Orlando, Florida, from March 16-20, 2025.
Attentive Science is attending the American College of Toxicology (ACT) 2024 Conference.
Join us at the Annual Safety Pharmacology Society Meeting, where Attentive Science will showcase its expertise in pharmaceutical nonclinical studies.
Join Us at the Animal Health Summit in Kansas! We are excited to participate in the upcoming Animal Health Summit at The Midland Theatre.
Attentive Science is proud to exhibit across three international pavilions at the BIO International Convention 2025.
Join Attentive at the NorCal SOT Spring Symposium 2025, a premier event for toxicology professionals.
Attentive Science is excited to attend the 64th Annual Society of Toxicology (SOT) Meeting & ToxExpo in Orlando, Florida, from March 16-20, 2025.
Attentive Science is attending the American College of Toxicology (ACT) 2024 Conference.
Join us at the Annual Safety Pharmacology Society Meeting, where Attentive Science will showcase its expertise in pharmaceutical nonclinical studies.
Join Us at the Animal Health Summit in Kansas! We are excited to participate in the upcoming Animal Health Summit at The Midland Theatre.